Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,255
datasets available to search
ShareScore release 0.9.0
Dataset results
3,255 results for “Pancreatic cancer”
Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00290693. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Proton Therapy in Adjuvant Pancreatic Cancer
ClinicalTrials.gov study NCT03885284. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01585805. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer
ClinicalTrials.gov study NCT02047474. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT01523457. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00398086. IPD Sharing: Not stated. Countries: 1. Publications: 2.
FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine
ClinicalTrials.gov study NCT02827201. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
ClinicalTrials.gov study NCT00482625. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA)
ClinicalTrials.gov study NCT00313560. IPD Sharing: NO. Countries: 1. Publications: 1.
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer
ClinicalTrials.gov study NCT00100815. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer
ClinicalTrials.gov study NCT02237157. IPD Sharing: NO. Countries: 1. Publications: 1.
APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT03087591. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01280058. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT02077881. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00696696. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT02839343. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Pre-operative Treatment for Patients With Untreated Pancreatic Cancer
ClinicalTrials.gov study NCT03138720. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.
ClinicalTrials.gov study NCT02332863. IPD Sharing: Not stated. Countries: 1. Publications: 19.
Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT02562898. IPD Sharing: YES. Countries: 1. Publications: 1.
Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01064622. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.